Hepatic Metastases Recruiting Phase 2 Trials for Floxuridine (DB00322)

Also known as: Liver Metastases / Metastases to liver / Metastatic neoplasm of liver / Cancer of liver, secondary / Metastasis to liver / Malignant neoplasm of liver, specified as secondary

IndicationStatusPhase
DBCOND0032606 (Hepatic Metastases)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03366155Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the LiverTreatment
NCT03493061A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLMTreatment
NCT03856658Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver MetastasesTreatment